This invention provides a purified retro-retinoid compound characterized by a molecular mass of about 302 daltons. This invention also provides methods for enhancing transcription of a gene regulated by retinoids in a cell as well as methods for treating disorders characterized by vitamin A deficiency.
Therapeutic tool
Dr. Jochen Buck
US patents issued:
Sharon Seiler, PhD
Tel: 212-639-6181, Fax: 212-717-3439
E-mail: seilers@mskcc.org